The Development of an Opiate Withdrawal Scale (OWS)
- 1 October 1987
- journal article
- research article
- Published by Wiley in British Journal of Addiction
- Vol. 82 (10) , 1139-1142
- https://doi.org/10.1111/j.1360-0443.1987.tb03294.x
Abstract
Summary: Withdrawal symptoms are feared by many addicts and, according to behavioural models, provide negative reinforcement for continued drug taking. Furthermore, conditioning models emphasize the role of conditioned withdrawal in precipitating relapse. A satisfactory scale for measuring withdrawal symptoms would aid the evaluation of these models and it would provide practical benefits in allowing more precise and economical use of drugs during drug withdrawal procedures. The development of such a scale, the OWS, is described. A principal components analysis showed that a single factor (severity) adequately accounted for the results. The scale has good discriminative efficiency in showing clear differences between withdrawal and post‐withdrawal phases of treatment. It also discriminates clearly between those undergoing withdrawal and controls. Concurrent validity is shown by agreement with observers' ratings of withdrawal severity at high levels of severity. At lower levels, the OWS appears to be more sensitive than observers' ratings.This publication has 10 references indexed in Scilit:
- An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedureAddictive Behaviors, 1986
- The Influence of Psychological Factors on the Opiate Withdrawal SyndromeThe British Journal of Psychiatry, 1986
- The Clinical Effectiveness of Electrostimulation vs Oral Methadone in Managing Opiate WithdrawalThe British Journal of Psychiatry, 1984
- Patient perspectives of opiate withdrawalDrug and Alcohol Dependence, 1983
- Opioid DependencePublished by Springer Nature ,1980
- Conditioned Narcotic Withdrawal in HumansScience, 1977
- The Scree Test For The Number Of FactorsMultivariate Behavioral Research, 1966
- THE ADDICTION LIABILITY OF METHADON (AMIDONE, DOLOPHINE, 10820) AND ITS USE IN THE TREATMENT OF THE MORPHINE ABSTINENCE SYNDROMEAmerican Journal of Psychiatry, 1949
- RECENT PROGRESS IN RESEARCH ON THE NEUROPHYSIOLOGIC BASIS OF MORPHINE ADDICTIONAmerican Journal of Psychiatry, 1948
- CLINICAL STUDIES OF DRUG ADDICTION, IIIAmerican Journal of Psychiatry, 1938